Literature DB >> 22031317

Heterogeneity of large cell carcinoma of the lung: an immunophenotypic and miRNA-based analysis.

Mattia Barbareschi1, Chiara Cantaloni, Valerio Del Vescovo, Alberto Cavazza, Valentina Monica, Rodolfo Carella, Giulio Rossi, Luca Morelli, Alberto Cucino, Massimo Silvestri, Giuseppe Tirone, Giuseppe Pelosi, Paolo Graziano, Mauro Papotti, Paolo Dalla Palma, Claudio Doglioni, Michela Alessandra Denti.   

Abstract

Large cell carcinomas (LCCs) of the lung are heterogeneous and may be of different cell lineages. We analyzed 56 surgically resected lung tumors classified as LCC on the basis of pure morphologic grounds, using a panel of immunophenotypic markers (adenocarcinoma [ADC]-specific, thyroid transcription factor-1, cytokeratin 7, and napsin A; squamous cell carcinoma [SQCC]-specific, p63, cytokeratin 5, desmocollin 3, and Δnp63) and the quantitative analysis of microRNA-205 (microRNA sample score [mRSS]). Based on immunoprofiles 19 (34%) of the cases were reclassified as ADC and 14 (25%) as SQCC; 23 (41%) of the cases were unclassifiable. Of these 23 cases, 18 were classified as ADC and 5 as SQCC according to the mRSS. Our data show that an extended panel of immunohistochemical markers can reclassify around 60% of LCCs as ADC or SQCC. However, a relevant percentage of LCCs may escape convincing immunohistochemical classification, and mRSS could be used for further typing, but its clinical relevance needs further confirmation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22031317     DOI: 10.1309/AJCPYY79XAGRAYCJ

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  8 in total

1.  Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology.

Authors:  G Rossi; M C Mengoli; A Cavazza; D Nicoli; M Barbareschi; C Cantaloni; M Papotti; A Tironi; P Graziano; M Paci; A Stefani; M Migaldi; G Sartori; G Pelosi
Journal:  Virchows Arch       Date:  2013-11-13       Impact factor: 4.064

Review 2.  MicroRNAs as lung cancer biomarkers.

Authors:  Valerio Del Vescovo; Margherita Grasso; Mattia Barbareschi; Michela A Denti
Journal:  World J Clin Oncol       Date:  2014-10-10

3.  Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma.

Authors:  Natasha Rekhtman; Laura J Tafe; Jamie E Chaft; Lu Wang; Maria E Arcila; Agnes Colanta; Andre L Moreira; Maureen F Zakowski; William D Travis; Camelia S Sima; Mark G Kris; Marc Ladanyi
Journal:  Mod Pathol       Date:  2012-11-30       Impact factor: 7.842

4.  Identification of new p53 target microRNAs by bioinformatics and functional analysis.

Authors:  Alessandra Bisio; Veronica De Sanctis; Valerio Del Vescovo; Michela A Denti; Anil G Jegga; Alberto Inga; Yari Ciribilli
Journal:  BMC Cancer       Date:  2013-11-21       Impact factor: 4.430

5.  A retrospective analysis of the clinicopathological characteristics of large cell carcinoma of the lung.

Authors:  Rui Liang; Tian-Xing Chen; Zhi-Qiang Wang; Ke-Wei Jin; Lian-Yu Zhang; Qing-Na Yan; Hui-Hua Zhang; Wan-Pu Wang
Journal:  Exp Ther Med       Date:  2014-11-17       Impact factor: 2.447

6.  Mutational and gene fusion analyses of primary large cell and large cell neuroendocrine lung cancer.

Authors:  Anna Karlsson; Hans Brunnström; Kajsa Ericson Lindquist; Karin Jirström; Mats Jönsson; Frida Rosengren; Christel Reuterswärd; Helena Cirenajwis; Åke Borg; Per Jönsson; Maria Planck; Göran Jönsson; Johan Staaf
Journal:  Oncotarget       Date:  2015-09-08

7.  Unravelling the Long Non-Coding RNA Profile of Undifferentiated Large Cell Lung Carcinoma.

Authors:  Sudhanshu Shukla
Journal:  Noncoding RNA       Date:  2018-02-05

8.  miR375-3p Distinguishes Low-Grade Neuroendocrine From Non-neuroendocrine Lung Tumors in FFPE Samples.

Authors:  Simone Detassis; Valerio Del Vescovo; Margherita Grasso; Stefania Masella; Chiara Cantaloni; Luca Cima; Alberto Cavazza; Paolo Graziano; Giulio Rossi; Mattia Barbareschi; Leonardo Ricci; Michela Alessandra Denti
Journal:  Front Mol Biosci       Date:  2020-05-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.